Gerald R. Ewoldt

Array ( [id] => 10685870 [patent_doc_number] => 20160032016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'MOLECULES AND METHODS FOR TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 14/882036 [patent_app_country] => US [patent_app_date] => 2015-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17798 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12057207 [patent_doc_number] => 20170333551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'USE OF SUPERANTIGENS FOR IMPROVING MUCOSAL ALLERGEN SPECIFIC IMMUNOTHERAPY IN HUMAN BEINGS' [patent_app_type] => utility [patent_app_number] => 15/519464 [patent_app_country] => US [patent_app_date] => 2015-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10560 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11850316 [patent_doc_number] => 20170224809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'USE OF SUPERANTIGENS FOR IMPROVING MUCOSAL ALLERGEN SPECIFIC IMMUNOTHERAPY IN NON-HUMAN MAMMALS' [patent_app_type] => utility [patent_app_number] => 15/519493 [patent_app_country] => US [patent_app_date] => 2015-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11058 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10749784 [patent_doc_number] => 20160095935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'CONJUGATES COMPRISING MANNAN AND MYELIN BASIC PROTEIN (MBP)' [patent_app_type] => utility [patent_app_number] => 14/877679 [patent_app_country] => US [patent_app_date] => 2015-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14416 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14877679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662296 [patent_doc_number] => 20160008440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'Use of CD83 in Combination Therapies' [patent_app_type] => utility [patent_app_number] => 14/872356 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24632 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10988897 [patent_doc_number] => 20160185842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => '14-3-3 Antagonists for the Prevention and Treatment of Arthritis' [patent_app_type] => utility [patent_app_number] => 14/873157 [patent_app_country] => US [patent_app_date] => 2015-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27335 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11995434 [patent_doc_number] => 20170299589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'Methods to Diagnose and Treat Multiple Sclerosis via Detection of Altered Protein Components of Serum' [patent_app_type] => utility [patent_app_number] => 15/510206 [patent_app_country] => US [patent_app_date] => 2015-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13483 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12091323 [patent_doc_number] => 20170348415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'TOLEROGENIC COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 15/508221 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 99433 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10714211 [patent_doc_number] => 20160060358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE' [patent_app_type] => utility [patent_app_number] => 14/837941 [patent_app_country] => US [patent_app_date] => 2015-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17785 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10820500 [patent_doc_number] => 20160166664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE' [patent_app_type] => utility [patent_app_number] => 14/807397 [patent_app_country] => US [patent_app_date] => 2015-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24106 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14807397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10679563 [patent_doc_number] => 20160025707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE' [patent_app_type] => utility [patent_app_number] => 14/806467 [patent_app_country] => US [patent_app_date] => 2015-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15203 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14806467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16800215 [patent_doc_number] => 10995136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-04 [patent_title] => 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis [patent_app_type] => utility [patent_app_number] => 14/798398 [patent_app_country] => US [patent_app_date] => 2015-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20448 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10421132 [patent_doc_number] => 20150306143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'COMPOSITIONS FOR TREATING AN INFLAMMATORY AUTOIMMUNE CONDITION' [patent_app_type] => utility [patent_app_number] => 14/796284 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8262 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10678046 [patent_doc_number] => 20160024192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'MOLECULAR CONJUGATES COMPRISING HUMAN MONOCLONAL ANTIBODIES TO DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 14/750057 [patent_app_country] => US [patent_app_date] => 2015-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28191 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14750057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10422593 [patent_doc_number] => 20150307603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'ANTI-INFLAMMATORY AGENTS' [patent_app_type] => utility [patent_app_number] => 14/742990 [patent_app_country] => US [patent_app_date] => 2015-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18921 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14742990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13316871 [patent_doc_number] => 20180209973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => DETECTION OF AUTOANTIBODIES AGAINST THE TSH RECEPTOR [patent_app_type] => utility [patent_app_number] => 15/320437 [patent_app_country] => US [patent_app_date] => 2015-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11742877 [patent_doc_number] => 20170196949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY' [patent_app_type] => utility [patent_app_number] => 15/315557 [patent_app_country] => US [patent_app_date] => 2015-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32043 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11604078 [patent_doc_number] => 20170121379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'USING B-CELL-TARGETING ANTIGEN IGG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 15/309026 [patent_app_country] => US [patent_app_date] => 2015-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14106 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11864799 [patent_doc_number] => 20170232083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'METHODS OF DIAGNOSIS AND TREATMENT OF CELIAC DISEASE IN CHILDREN' [patent_app_type] => utility [patent_app_number] => 15/306154 [patent_app_country] => US [patent_app_date] => 2015-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 40330 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14390885 [patent_doc_number] => 10308712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-04 [patent_title] => Antibodies that bind human cannabinoid 1 (CB1) receptor [patent_app_type] => utility [patent_app_number] => 14/774582 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 57 [patent_no_of_words] => 42290 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774582 [rel_patent_id] =>[rel_patent_doc_number] =>)